A Phase IV, randomized, single-blind, placebo-controlled, multi-center study to evaluate the immunogenicity of pneumococcal and influenza vaccines in adult subjects with rheumatoid arthritis receiving Study Drug or placebo.
Explore related content and topics
White Paper
Alzheimer's Disease Research 2018
PRA conducted a survey at the 2018 Alzheimer's Association International Conference in Chicago. Across the board we found that the research community…
View Resource
Page
Predictivv™
The landscape of clinical development is continually evolving, but the end goal of trial design hasn’t changed. As a global CRO, our priority is to…
Read More
Page
Biosimilars
Our collaborative, cross-functional team develops tailored, cost-effective services to meet the unique needs of biosimilars clinical development.
Read More
View all related content and resources for Patient Recruitment and Retention
Explore Insights